GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Other Current Liabilities

DuoGenic StemCells (ROCO:7607) Other Current Liabilities : NT$0.12 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Other Current Liabilities?

DuoGenic StemCells's other current liabilities for the quarter that ended in Jun. 2024 was NT$0.12 Mil.

DuoGenic StemCells's quarterly other current liabilities stayed the same from Jun. 2023 (NT$0.12 Mil) to Dec. 2023 (NT$0.12 Mil) but then from Dec. 2023 (NT$0.12 Mil) to Jun. 2024 (NT$0.12 Mil).

DuoGenic StemCells's annual other current liabilities declined from Dec. 2021 (NT$0.34 Mil) to Dec. 2022 (NT$0.13 Mil) and declined from Dec. 2022 (NT$0.13 Mil) to Dec. 2023 (NT$0.12 Mil).


DuoGenic StemCells Other Current Liabilities Historical Data

The historical data trend for DuoGenic StemCells's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Other Current Liabilities Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23
Other Current Liabilities
- - -

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Liabilities Get a 7-Day Free Trial - - - - -

DuoGenic StemCells Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


DuoGenic StemCells Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


DuoGenic StemCells Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines